Avid Bioservices Inc (CDMO)

[EYEBUYSTOX]

You make an interesting observation. Assuming that the same institution(s) has been manipulating this stock for the past year in hopes of accumulating, shorting on the Feb. 13, 2013 PR would generate long term capital gains if they cover or receive the shares via the S-3 if it doesn't happen until Feb. 14. That EASL on Feb. 13/14 would time it perfectly.

It's becoming clear to me that this long term game of games being played with the share price will take on a new chapter in dramatic fashion in the coming weeks, most likely by Feb. 15 IMO.

In retrospect, does news about a pancreatic cancer trial that was an afterthought justify 30 million shares being traded? Especially when you consider only 21 million were traded when the phase 3 announcement was made. It was most likely shorting against the box by the same institution who bought most of the company on Sept. 24, 2012 and Jan 7, 2013 IMO.